Dermatomyositis Flashcards

1
Q

Forms of dermatomyositis

A
  • Classic dermatomyositis (autoimmune disease affecting both muscle and skin)
  • Amyopathic dermatomyositis (autoimmune disease affecting just skin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Muscle involvement in dermatomyositis

A
  • Symmetric weakness in proximal limb muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complications of dermatomyositis

A
  • Malignancy
  • Systemic involvement (esp. lungs)
  • Diaphragm atrophy
  • Calcinosis cutis (calcium deposits in skin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Classic presentation for dermatomyositis

A
  • Skin-wide poikiloderma and pink-violaceous rash often with heliotropic distribution (periocular) and scalp distribution
  • Rashes worsen substantially with sunlight, and esp. prominent in neck area due to sun exposure (V-neck sign, shawl sign)
  • Muscle weakness in brachium and thigh
  • High creatine kinase levels (from muscle degradation)
  • Streaks of red in nailfolds
  • Flares triggered by stress
  • Grotton’s papules in MCPs, PIPs, and/pr DIPs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patients with dermatomyositis often first present to clinic with chronic mild symptoms that are acutely worsening during ____

A

Patients with dermatomyositis often first present to clinic with chronic mild symptoms that are acutely worsening during a period of social stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Poikiloderma

A
  • Pink-violet rash consisting of areas of hyperpigmentation, hypopigmentation, telangiectasis (widening of blood vessels), and atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Onset of dermatomyositis is associated with . . .

A

. . . an external trigger that interacts with the immune system. Usually a drug or infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Emerging evidence implicates ___ as the source of pathology in dermatomyositis. This also implicates ___ as the source of ___.

A

Emerging evidence implicates IFNβ as the source of pathology in dermatomyositis. This also implicates plasmacytoid dendritic cells (pDCs) as the source of IFNβ.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathognomonic features of dermatomyositis

A
  • Heliotrope eruption
  • Grotton’s papules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Grotton’s papules are often confused for. . .

A

. . . psoriasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cutis cacinosis is often confused for. . .

A

. . . tophi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A

Grotton’s papules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A

Heliotrope sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
A

Heliotrope sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lab findings of dermatomyositis

A
  • Elevated creatine kinase
  • Elevated lactate dehydrogenase
  • Elevated aldolase
  • Elevated liver enzymes (ALT AST)
  • Imaging studies of muscle to establish atrophy (EMG, MRI, biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Systemic symptoms of dermatomyositis

A
  • Interstitial lung disease (15-30%, antisynthetase syndrome)
  • Liver disease
  • Muscle degradation
  • Increased risk of malignancy
  • Fever
17
Q

Antisynthetase syndrome

A
  • Associated with antisynthetase autoantibodies, esp. Jo-1
  • Fever
  • Erosive polyarthritis
  • “Mechanic’s hands” -> hyperkeratosis, fissuring of lateral and palmar aspects of hand
  • Reynaud’s phenomenon
  • Interstitial lung disease (70% of patients with anti-Jo-1 go on to develop)
18
Q

When dermatomyositis and a malignancy are diagnosed in a close time fashion, the dermatomyositis may be thought of as ____

A

When dermatomyositis and a malignancy are diagnosed in a close time fashion, the dermatomyositis may be thought of as a paraneoplastic phenomenon

19
Q

Treatment for dermatomyositis

A
  • Corticosteroids
  • Methotrexate
  • IVIG